INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1434534146-neurologic-disease]( "VEGF Signaling Pathway")
VEGF Signaling PathwayIn Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.
-
![GettyImages-1914829121-rna-strands-molecule]( "Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines")
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP VaccinesDiscover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
-
![Lipid Nanoparticles GettyImages-1437855772]( "How Lipid Nanoparticles Enable Next-Gen Delivery")
How Lipid Nanoparticles Enable Next-Gen DeliveryCell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.
-
![iStock-459537393-pill-softgel-capsule]( "Overcoming Food Effects, Variability, Solubility For A Non-Opioid Analgesic With Lipid-Based Formulations")
Overcoming Food Effects, Variability, Solubility For A Non-Opioid Analgesic With Lipid-Based FormulationsDevelop optimized lipid-based formulations to overcome solubility, stability, and food-effect challenges, enabling high-dose oral delivery and rapid progression to Phase 1 trials.
-
Creative Chromatography Solutions For Complex Small Molecules6/18/2026
Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.
-
Lonza Advanced Synthesis Capabilities Update February 2026: AI Drug Development3/2/2026
Learn how our scientists accurately predict and identify the most stable cocrystal forms by leveraging advanced machine learning models, enhancing efficiency and reducing development risks.
-
Best-In-Class Nanodevelopment Capabilities2/3/2025
A highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.
-
Bridging The Gap Between Traditional Models And Human Biology9/3/2024
Whether you are new to Organ-on-a-Chip technology or seeking to expand your expertise, watch to gain the knowledge and insights needed to effectively implement this technology into your research.
-
Benchmarking Filtration Performance Of TFF Cassettes5/30/2025
Optimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-1166528597-scientist-lab-equipment-tubing]( "Accelerate Drug Development With Reliable Pharmaceutical Research")
Tailored support is available for diverse molecules, including small and large molecules, nucleic acid therapies, and novel delivery systems. Services span drug substance to regulatory affairs.
-
![Decision Making GettyImages-872555022]( "Which Organ-Chip Design Is Right For You?")
Explore detailed product specifications and utilize a helpful decision tree to determine which organ-chip best meets the needs of your research.
-
![GettyImages-849207658 Drug toxicity concept]( "Drug Product Development And Manufacturing Services")
Backed by trusted data and deep scientific expertise, learn how our adaptive approach ensures seamless progression from preclinical development to commercial manufacturing.
-
![Solutions For Injectables]( "Solutions For Injectables And Parenteral Formulations")
Sterility is key for high-risk applications such as injectables, parenteral formulations, ophthalmic and peritoneal dialysis solutions, and many more.
-
![GettyImages-899692950-cleanroom-microscopes-scientists-analyze]( "High Potency Handling Capabilities And Support")
Highly potent APIs require stringent containment and precise manufacturing controls. Specialized facilities offer end-to-end development solutions and robust cross-contamination protections.
